샘플 요청 목록

 카트 문의
시장보고서
상품코드
1792916

세계의 반맹(헤미아노프시아) 시장

Hemianopsia
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 364 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

반맹(헤미아노프시아) 세계 시장은 2030년까지 5억 320만 달러에 달할 전망

2024년에 3억 7,520만 달러로 추정되는 반맹(헤미아노프시아) 세계 시장은 2030년에는 5억 320만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 5.0%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 동측반맹은 CAGR 4.4%를 기록하며 분석 기간 종료시에는 3억 760만 달러에 달할 것으로 예측됩니다. 사분맹 부문의 성장률은 분석 기간 동안 CAGR 5.7%로 추정됩니다.

미국 시장은 1억 220만 달러로 추정, 중국은 CAGR 7.8%로 성장 예측

미국의 반맹(헤미아노프시아) 시장은 2024년에 1억 220만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 7.8%로서 2030년에는 예측 시장 규모 9,910만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.5%와 5.0%로 예측됩니다. 유럽에서는 독일이 CAGR 3.2%로 성장할 것으로 예측됩니다.

세계의 반맹(헤미아노프시아) 치료 시장 - 주요 동향과 촉진요인 정리

신경학적 이해가 깊어지면 반맹증(hemianopsia) 관리가 개선될 수 있을까?

반맹(헤미아노프시아)은 한쪽 눈 또는 양쪽 눈의 시야의 절반이 보이지 않는 것을 특징으로 하는 질환으로, 특히 뇌졸중, 뇌손상, 종양 등으로 인한 신경손상의 결과로 오랫동안 난제로 여겨져 왔습니다. 그러나 신경과학과 임상 영상 진단의 발전으로 현재 이 병에 대한 보다 정교하고 섬세한 이해가 이루어지고 있으며, 관리 전략을 개선할 수 있는 길이 열리고 있습니다. 역사적으로 반맹(헤미아노프시아)은 대뇌피질 손상으로 인한 돌이킬 수 없는 결과로 여겨져 치료 옵션이 거의 없었습니다. 그러나 기능적 MRI, 확산텐서영상, 신경안 매핑의 등장으로 임상의들은 시각 경로의 정확한 위치와 장애 정도를 이전과는 비교할 수 없을 정도로 정확하게 파악할 수 있게 되었습니다. 이러한 해부학적 인사이트 향상으로 환자별 신경장애 및 시야 결손에 따른 맞춤형 재활 프로그램 개발이 가능해졌습니다. 또한, 신경가소성(뇌가 스스로 재구성하는 능력)에 대한 보다 종합적인 이해를 통해 뇌의 손상되지 않은 영역을 자극하여 시야 결손을 보완하는 것을 목표로 하는 혁신적인 치료법이 개발되었습니다. 이러한 치료법에는 시각 회복 훈련, 보상 스캐닝 전략, 시각 회로와 주의 회로 모두에 작용하도록 고안된 인지 지각 연습 등이 있습니다. 작업치료와 신경-시각 재활의 통합도 환자가 시각장애에 보다 효과적으로 적응할 수 있도록 돕고 있습니다. 임상 프로토콜은 점점 더 다학제화되어 신경과 의사, 안과 의사, 검안사, 물리치료사, 심지어 심리학자까지 참여하여 전인적 회복에 기여하고 있습니다. 이러한 신경학적 인사이트의 증가는 진단의 명확성을 향상시킬 뿐만 아니라 반맹(헤미아노프시아) 치료와 기능 회복에 있어 가능한 것을 재정의하고 있습니다.

보조기술과 시각보조기구가 환자의 일상을 변화시킬 수 있을까?

혁신적인 보조 기술은 환자들에게 보다 독립적이고 안전하게 일상생활을 영위할 수 있는 실용적인 도구를 제공함으로써 반맹(헤미아노프시아) 치료의 상황을 빠르게 변화시키고 있습니다. 가장 영향력 있는 발전 중 하나는 프리즘 렌즈와 같은 특수 시야 확대 장치의 개발입니다. 이러한 기구를 올바르게 착용하고 훈련과 함께 사용하면 환자의 독서, 보행, 장애물 회피 능력이 현저하게 향상되는 것으로 나타났습니다. 증강현실(AR)과 인공지능(AI) 알고리즘을 탑재한 웨어러블 헤드셋이 개발되어 사각지대에 있는 위험을 감지하고 경고합니다. 시선의 움직임을 추적하고 피드백에 기반한 훈련을 제공하는 스마트폰 애플리케이션은 특히 운전이나 혼잡한 환경에서의 내비게이션과 같은 복잡한 작업 중에 환자가 시각적 스캐닝 행동을 재교육하는 데 도움이 되고 있습니다. 스크린 리더 기능 강화, 고대비 디스플레이 설정, 적응형 조명 등은 반맹(헤미아노프시아) 환자들이 직업 및 학업 환경에서 더 많은 도움을 받을 수 있도록 도와줍니다. 가상현실(VR) 기반 재활도 유망한 분야로, 몰입형 훈련 모듈을 통해 실제 시나리오를 시뮬레이션하고 안전하고 통제된 환경에서 보상 전략을 장려할 수 있습니다. 하드웨어뿐만 아니라 잔존 시야를 강화하고 주의력 배분을 개선하기 위해 소프트웨어 기반의 시각 자극 재훈련 운동을 도입한 치료 프로그램도 등장하고 있습니다. 공공 및 민간 의료기관은 환자 치료 결과를 개선하기 위해 이러한 기술에 대한 투자를 늘리고 있으며, 일부 장비에 대한 보험 환급도 점차 확대되고 있습니다. 광학, 소프트웨어, 신경 재활의 융합은 과거에는 정적인 장애였던 것을 적응 기능의 진정한 잠재력을 가진 관리 가능한 상태로 바꾸고 있습니다.

뇌졸중 회복은 반맹(헤미아노프시아) 치료 모델의 방향성에 영향을 미치고 있는가?

뇌졸중이 반맹(헤미아노프시아)의 주요 원인임을 감안할 때, 뇌졸중 치료 및 재활 프로토콜의 발전은 시야 결손의 치료 및 관리에 직접적이고 중요한 영향을 미치고 있습니다. 뇌졸중 후 치료 모델이 통합적이고 환자 중심의 프레임워크를 채택함에 따라, 반맹증(hemianopsia)은 이전보다 더 빠르고 체계적으로 다루어지고 있습니다. 신속한 뇌졸중 대응 시스템 및 급성기 치료 경로에는 현재 표준 평가의 일부로 시야 평가가 포함되어 있어 반맹(헤미아노프시아)의 신속한 진단 및 조기 개입이 가능합니다. 시각 재활은 아급성기 회복기(보통 뇌졸중 발병 후 몇 주 이내)에 시작하는 것이 가장 효과적이기 때문에 조기 발견이 매우 중요합니다. 물리치료, 작업치료, 시력치료가 결합되어 환자가 이동, 독서, 공간 탐색과 같은 중요한 기술을 재학습할 수 있도록 다학제적 재활치료팀이 더욱 긴밀하게 협력하고 있습니다. 또한, 뇌졸중 후 신경 회복에 대한 연구는 기능적 보상에 중요한 신경 가소성을 향상시키는 반복적인 목표지시형 운동의 사용을 장려하고 있습니다. 현재 재활시설에서는 시뮬레이션에 기반한 훈련과 주방, 도로, 사무실 등 실제 생활환경을 모방한 적응 장비를 도입하여 시각장애가 있어도 안전하고 독립적인 생활을 할 수 있는 방법을 환자들에게 지도하고 있습니다. 또한, 뇌졸중 예방과 회복에 초점을 맞춘 공중 보건 노력은 시력 회복 훈련을 포함한 프로그램에 자금을 지원함으로써 간접적으로 환자들을 돕고 있습니다. 가족 참여와 환자 교육은 환자가 시력 상실을 인식하고 보다 효과적으로 적응할 수 있도록 돕는 회복의 필수적인 요소입니다. 궁극적으로 반맹증(hemianopsia)을 뇌졸중 회복의 넓은 틀에 포함시킴으로써 인지도를 높이고, 치료의 질을 향상시키며, 전 세계 환자들의 장기적인 결과를 개선하고 있습니다.

반맹(헤미아노프시아) 치료 시장의 성장과 혁신을 촉진하는 주요 요인은 무엇인가?

반맹(헤미아노프시아) 치료 시장의 성장은 기술 발전, 신경 질환의 증가, 인구 고령화, 환자의 기대치 변화에 따른 여러 요인에 의해 주도되고 있습니다. 전 세계적으로 뇌졸중, 외상성 뇌손상, 뇌종양 발병률이 증가함에 따라 반맹증(hemianopsia) 치료의 환자층이 확대되고 있으며, 특히 북미, 유럽, 아시아태평양에서 고령화가 진행되고 있습니다. 첨단 영상 진단 기술의 발달과 함께 반맹(헤미아노프시아)의 조기 및 정확한 발견이 용이해져 전문 재활 서비스에 적시에 의뢰할 수 있게 되었습니다. 기술 혁신은 주요 성장 동력이며, 프리즘 광학, AR/VR 시스템, 시력 훈련 소프트웨어의 지속적인 발전으로 삶의 질을 향상시키고 치료 옵션을 확대하는 신제품이 시장에 출시되고 있습니다. 의료 시스템은 시력 결손의 기능적 영향을 점점 더 인식하고 있으며, 시력 재활을 신경학, 뇌졸중, 작업 치료 프로그램에 통합하고 있습니다. 또한, 신경 재활 연구에 대한 투자가 증가하고 있으며, 뇌-컴퓨터 인터페이스 시스템, 경두개 자기 자극(TMS) 등 시각 장애를 회복하거나 보완할 수 있는 새로운 접근법이 발견되고 있습니다. 소비자의 행동도 진화하고 있습니다. 오늘날의 환자들은 보다 적극적이고, 디지털에 대한 인식이 높으며, 자립과 사회 참여를 가능하게 하는 솔루션을 찾는 데 투자하고 있습니다. 원격의료와 가상 진료 플랫폼의 성장으로 시력 치료는 특히 의료 서비스가 부족한 지역과 농촌 지역에서 더욱 친근하게 다가갈 수 있게 되었습니다. 또한, 정부와 NGO는 시각장애인을 위한 인식개선 캠페인과 지원 기술 보급에 자금을 지원하며 시장 보급에 힘을 보태고 있습니다. 마지막으로, 보험 적용 범위의 확대와 새로운 보조기구에 대한 규제 당국의 승인으로 인해 경제적 장벽이 낮아져 환자와 의료진 모두 이러한 혁신을 채택하고 있습니다. 이러한 촉진요인들이 복합적으로 작용하여 과거에는 틈새 시장으로 여겨졌던 시장이 의료적으로나 기술적으로나 역동적인 복합 분야로 확대되고 있습니다.

부문

유형(동측반맹, 사분맹, 양이측반맹), 치료(시력 회복, 시야 확대 보조), 최종사용자(병원 최종사용자, 전문 클리닉 최종사용자)

조사 대상 기업 사례

  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • Bioness, Inc.
  • Carl Zeiss Meditec AG
  • Chadwick Optical
  • EssilorLuxottica
  • EyeTech Digital Systems
  • F. Hoffmann-La Roche Ltd.
  • Haag-Streit Holding
  • Healio
  • Heidelberg Engineering
  • Linari Medical
  • NeuroVision Imaging LLC
  • Novartis AG
  • RetroSense Therapeutics, LLC
  • Second Sight Medical Products, Inc.
  • Sight Sciences
  • VisionCare, Inc.
  • Vivid Vision
  • Vycor Medical Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.27

Global Hemianopsia Market to Reach US$503.2 Million by 2030

The global market for Hemianopsia estimated at US$375.2 Million in the year 2024, is expected to reach US$503.2 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Homonymous Hemianopsia, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$307.6 Million by the end of the analysis period. Growth in the Quadrantanopsia segment is estimated at 5.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$102.2 Million While China is Forecast to Grow at 7.8% CAGR

The Hemianopsia market in the U.S. is estimated at US$102.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$99.1 Million by the year 2030 trailing a CAGR of 7.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global Hemianopsia Treatment Market - Key Trends & Drivers Summarized

Is Greater Neurological Understanding Leading to Better Hemianopsia Management?

Hemianopsia, a condition characterized by the loss of vision in half of the visual field of one or both eyes, has long been a challenging consequence of neurological damage, especially from strokes, brain injuries, and tumors. However, advances in neuroscience and clinical imaging are now driving a more targeted and nuanced understanding of the condition, paving the way for improved management strategies. Historically, hemianopsia was considered a largely irreversible outcome of cortical damage, with few therapeutic options. But with the advent of functional MRI, diffusion tensor imaging, and neuro-ophthalmological mapping, clinicians can now pinpoint the exact location and extent of visual pathway disruptions with unprecedented accuracy. This improved anatomical insight has enabled the development of individualized rehabilitation programs that are tailored to the patient’s specific neural deficits and visual field loss. Additionally, a more comprehensive understanding of neuroplasticity-the brain's ability to reorganize itself-has led to innovative therapies aimed at stimulating undamaged areas of the brain to compensate for visual field deficits. These therapies include visual restoration training, compensatory scanning strategies, and cognitive-perceptual exercises designed to engage both visual and attentional circuits. Integration of occupational therapy with neuro-visual rehabilitation is also helping patients adapt more effectively to their vision loss. Clinical protocols are increasingly multidisciplinary, involving neurologists, ophthalmologists, optometrists, physiotherapists, and even psychologists, all of whom contribute to holistic recovery. This growing body of neurological insight is not only improving diagnostic clarity but also redefining what is possible in hemianopsia treatment and functional recovery.

Are Assistive Technologies and Visual Aids Transforming Daily Life for Patients?

Innovative assistive technologies are rapidly altering the landscape of hemianopsia treatment by providing patients with practical tools to navigate daily life more independently and safely. One of the most impactful advancements has been the development of specialized visual field expanders, such as prism lenses, which shift images from the blind side into the seeing side of the visual field, thereby increasing environmental awareness. These devices, when fitted correctly and combined with training, have shown significant improvements in patients’ ability to read, walk, and avoid obstacles. Digital solutions are also making an impact-wearable headsets equipped with augmented reality (AR) and artificial intelligence (AI) algorithms are being developed to detect and alert users to hazards in their blind fields. Smartphone applications that track eye movement and offer feedback-based training are helping patients to retrain their visual scanning behaviors, especially during complex tasks like driving or navigating busy environments. Screen reader enhancements, high-contrast display settings, and adaptive lighting are further supporting those with hemianopsia in occupational and academic settings. Virtual reality (VR)-based rehabilitation is another promising field, with immersive training modules that simulate real-world scenarios and encourage compensatory strategies in a safe, controlled environment. Beyond the hardware, therapy programs are also incorporating software-based visual stimuli retraining exercises to strengthen residual visual fields and improve attention allocation. Public and private health institutions are increasingly investing in these technologies to improve patient outcomes, and insurance reimbursement for some of these devices is gradually expanding. The convergence of optics, software, and neuro-rehabilitation is turning what was once a static disability into a manageable condition with real possibilities for adaptive functionality.

Is Stroke Recovery Influencing the Direction of Hemianopsia Care Models?

Given that strokes are the leading cause of hemianopsia, the evolution of stroke care and rehabilitation protocols is having a direct and significant impact on the treatment and management of visual field loss. As post-stroke care models increasingly adopt integrated and patient-centered frameworks, hemianopsia is being addressed earlier and more systematically than ever before. Rapid stroke response systems and acute care pathways now include visual field assessments as part of their standard evaluations, enabling quicker diagnosis of hemianopsia and earlier intervention. This early detection is vital, as visual rehabilitation is most effective when begun during the subacute recovery phase-typically within weeks after the stroke. Multidisciplinary rehabilitation teams are working more cohesively, combining physical therapy, occupational therapy, and vision therapy to help patients relearn essential skills such as mobility, reading, and spatial navigation. Additionally, research into post-stroke neural recovery has prompted the use of repetitive, goal-directed exercises that enhance neuroplasticity, which is critical for functional compensation in hemianopsia. Rehabilitation facilities are now incorporating simulation-based training and adaptive equipment that mimic real-life environments, such as kitchens, roads, and offices, to teach patients how to live safely and independently with visual field deficits. Public health initiatives focused on stroke prevention and recovery are also indirectly benefiting hemianopsia patients by funding programs that include vision restoration training. Family involvement and patient education have become vital components of recovery, helping patients recognize and adapt to their vision loss more effectively. Ultimately, the incorporation of hemianopsia into the broader framework of stroke recovery is elevating its visibility, enhancing care quality, and improving long-term outcomes for patients worldwide.

What Key Factors Are Driving Growth and Innovation in the Hemianopsia Treatment Market?

The growth in the hemianopsia treatment market is driven by several factors rooted in technological advancement, increasing neurological disorders, aging populations, and evolving patient expectations. A rising global incidence of strokes, traumatic brain injuries, and brain tumors is expanding the patient base for hemianopsia treatment-particularly in aging populations across North America, Europe, and parts of Asia-Pacific. The parallel development of advanced diagnostic imaging technologies has made it easier to detect hemianopsia early and accurately, prompting timely referrals to specialized rehabilitation services. Technological innovation is a major growth engine, with continual advances in prism optics, AR/VR systems, and vision-training software introducing new products to market that improve quality of life and expand therapeutic options. Healthcare systems are increasingly recognizing the functional impact of visual field loss, leading to greater integration of vision rehabilitation into neurology, stroke, and occupational therapy programs. Moreover, increasing investments in neuro-rehabilitation research are uncovering novel approaches for restoring or compensating for visual deficits, such as brain-computer interface systems and transcranial magnetic stimulation (TMS). Consumer behavior is also evolving; patients today are more proactive, digitally aware, and invested in finding solutions that allow for independence and social participation. The growth of telemedicine and virtual care platforms has made vision therapy more accessible, especially in underserved or rural areas. Additionally, governments and NGOs are funding awareness campaigns and assistive technology distribution for individuals with vision impairments, boosting market adoption. Lastly, expanding insurance coverage and regulatory approvals for novel assistive devices are lowering financial barriers, encouraging both patients and providers to adopt these innovations. Together, these drivers are accelerating the expansion of a market once considered niche into a dynamic, multidisciplinary sector with substantial medical and technological momentum.

SCOPE OF STUDY:

The report analyzes the Hemianopsia market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Homonymous Hemianopsia, Quadrantanopsia, Bitemporal Hemianopsia); Treatment (Vision Restoration Therapy Treatment, Visual Field Expander Aid Treatment); End-Use (Hospitals End-Use, Specialty Clinics End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 37 Featured) -

  • AbbVie Inc.
  • Aerie Pharmaceuticals Inc.
  • Bioness, Inc.
  • Carl Zeiss Meditec AG
  • Chadwick Optical
  • EssilorLuxottica
  • EyeTech Digital Systems
  • F. Hoffmann-La Roche Ltd.
  • Haag-Streit Holding
  • Healio
  • Heidelberg Engineering
  • Linari Medical
  • NeuroVision Imaging LLC
  • Novartis AG
  • RetroSense Therapeutics, LLC
  • Second Sight Medical Products, Inc.
  • Sight Sciences
  • VisionCare, Inc.
  • Vivid Vision
  • Vycor Medical Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Hemianopsia - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Stroke and Traumatic Brain Injury Rates Throw the Spotlight on Hemianopsia Diagnosis and Treatment
    • Increased Focus on Neuro-Ophthalmology Care Propels Growth in Specialized Therapeutic Solutions
    • Expanding Awareness Among Neurologists and Optometrists Strengthens Business Case for Early Detection
    • Technological Advances in Visual Field Testing Drive Adoption of Accurate Diagnostic Tools
    • Innovation in Vision Restoration Therapies Generates Demand for Neuroplasticity-Based Treatments
    • Growing Use of Visual Aids and Compensatory Devices Expands Addressable Market for Assistive Solutions
    • Integration of Virtual Reality in Rehabilitation Programs Spurs Interest in Digital Therapy Approaches
    • Aging Population Trends Sustain Growth in Post-Stroke Vision Impairment Management
    • Improved Access to Stroke Rehabilitation Centers Drives Adoption of Multidisciplinary Hemianopsia Care
    • Cognitive and Psychological Impacts of Hemianopsia Generate Demand for Holistic Patient Management
    • Increasing Availability of Wearable Vision Technologies Accelerates Demand in Home-Based Care Settings
    • Delays in Diagnosis Due to Low Awareness Pose Challenges to Timely and Effective Treatment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hemianopsia Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Homonymous Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Homonymous Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Homonymous Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Quadrantanopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Quadrantanopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Quadrantanopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Bitemporal Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Bitemporal Hemianopsia by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Bitemporal Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vision Restoration Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Vision Restoration Therapy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Vision Restoration Therapy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Visual Field Expander Aid Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Visual Field Expander Aid Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Visual Field Expander Aid Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: China 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: China 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: China 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Hemianopsia by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: France 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: France 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: France 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 101: UK Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Hemianopsia by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 158: India Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: India 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: India 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: India 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Hemianopsia by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Hemianopsia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Hemianopsia by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Hemianopsia by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Hemianopsia Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Hemianopsia by Type - Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Hemianopsia by Type - Percentage Breakdown of Value Sales for Homonymous Hemianopsia, Quadrantanopsia and Bitemporal Hemianopsia for the Years 2014, 2025 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Hemianopsia by Treatment - Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Hemianopsia by Treatment - Percentage Breakdown of Value Sales for Vision Restoration Therapy Treatment and Visual Field Expander Aid Treatment for the Years 2014, 2025 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Hemianopsia by End-Use - Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Hemianopsia by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use and Specialty Clinics End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제